COVID-19 and innate immunity
DOI:
https://doi.org/10.56580/GEOMEDI0004Keywords:
COVID-19, interferon, cytokines, coronavirus, immunity, RNA, PAMP, DAMPAbstract
The human body fights many pathogens in the environment with different methods. One of them is immunity. There are innate and acquired immunities. The purpose of innate immunity is to maintain the body's own and biological individuality, to identify and destroy foreign substances and cells, including pathogenic bacteria and viruses, as well as tumor cells that have grown in the body. The innate immune response accomplishes this by means of myeloid lineage cells that have no strict specificity for antigens, do not elicit a clonal response, and have no memory for primary contact with a foreign agent. Acquired immunity has the ability to recognize and respond to individual antigens, characterized by a clonal response in which lymphoid cells are also involved. He has an immunological memory. The body responds to COVID-19 invasion with both innate and acquired immunity. This article reviews the innate immune response to the invasion of COVID-19 in the body.
Metrics
References
Charles Janeway et al. Immunobiology; Fifth Edition (неопр.). — New York and London: Garland Science (англ.). 2001. — ISBN 0-8153-4101-6.
Yusuke Kasuga et al. Innate immune sensing of coronavirus and viral evasion strategies. Experimental & Molecular Medicine 53, pages 723–736 (2021).
Fung, T. S. & Liu, D. X. Human coronavirus: host-pathogen interaction. Annu. Rev. Microbiol. 73, 529–557 (2019).
Tse, L. V., Meganck, R. M., Graham, R. L. & Baric, R. S. The current and future state of vaccines, antivirals and gene therapies against emerging coronaviruses. Front. Microbiol. 11, 658 (2020).
Li, F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 3, 237–261 (2016).
Thiel, V. et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84, 2305–2315 (2003).
Angelini, M. M., Akhlaghpour, M., Neuman, B. W. & Buchmeier, M. J. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio https://doi.org/10.1128/mBio.00524-13 (2013).
Subissi, L. et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc. Natl Acad. Sci. USA 111, E3900–E3909 (2014).
Snijder, E. J., Decroly, E. & Ziebuhr, J. The nonstructural proteins directing coronavirus rna synthesis and processing. Adv. Virus Res. 96, 59–126 (2016).
Eckerle, L. D., Lu, X., Sperry, S. M., Choi, L. & Denison, M. R. High fidelity of murine hepatitis virus replication is decreased in Nsp14 exoribonuclease mutants. J. Virol. 81, 12135–12144 (2007).
Ivanov, K. A. & Ziebuhr, J. Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5’-triphosphatase activities. J. Virol. 78, 7833–7838 (2004).
Chen, Y. et al. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2’-O-methylation by Nsp16/Nsp10 protein complex. PLoS Pathog. 7, e1002294 (2011).
Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein Nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 106, 3484–3489 (2009).
Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820 (2010).
Krieg, A. M. AIMing 2 defend against intracellular pathogens. Nat. Immunol. 11, 367–369 (2010).
Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).
Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730–737 (2004).
Geijtenbeek, T. B. & Gringhuis, S. I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465–479 (2009).
Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343–353 (2015).
Li, K. et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 9, e1003124 (2013).
Thiel, V. et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84, 2305–2315 (2003).
Spence, J. S. et al. IFITM3 directly engages and shuttles incoming virus particles to lysosomes. Nat. Chem. Biol. 15, 259–268 (2019).
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020).
Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255–2273 (2020).
